Stocks and Investing Stocks and Investing
Wed, August 12, 2020
Tue, August 11, 2020

Leland Gershell Downgraded (ALNY) to Hold and Decreased Target to $156 on, Aug 11th, 2020


Published on 2024-10-27 12:03:46 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Decreased Target from $162 to $156 on, Aug 11th, 2020.

Leland has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 4 agree with Leland's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $90 on, Friday, August 7th, 2020
  • Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $122 on, Thursday, May 28th, 2020
  • Luca Issi of "RBC Capital" Initiated at Hold and Held Target at $150 on, Wednesday, May 13th, 2020
  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Increased Target to $137 on, Thursday, May 7th, 2020


These are the ratings of the 5 analyists that currently disagree with Leland


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $197 on, Friday, August 7th, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, May 7th, 2020
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $171 on, Thursday, May 7th, 2020
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $160 on, Wednesday, May 6th, 2020
  • Christopher Marai of "Nomura" Maintained at Sell and Held Target at $74 on, Tuesday, April 14th, 2020
Contributing Sources